Funding Monitor

Advancing bio-printing of living cells for regenerative medicine

Today: 27/07/2026 ·  FUTURE  · Forthcoming  · Viewed

Last loaded 21/07/2026 13:07 UTC

Funding agency: Horizon Europe

Call: HORIZON-HLTH-2027-03

Type of action: HORIZON-RIA HORIZON Research and Innovation Actions  |  Deadline model: single-stage  |  Planned opening: 03/06/2027  |  Model Grant Agreement: HORIZON Action Grant Budget-Based

Developing and using new tools, technologies, and digital solutions for a healthy society. The call is focused on advancing bio-printing of living cells for regenerative medicine.

Budget total: 90000000.0 EUR  |  Budget per project: — EUR

Deadline: 22/09/2027 (422 days left)  |  Duration: 36 months  |  Funding intensity: —%  |  Type: research

Eligibility: entity types: legal entities, universities; countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden

#bio-printing#regenerative medicine#health technologies#digital solutions

HealthResearch & Development Digital solutions

Original listing ↗

Matching by organization

"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.

OrganizationMatch %SourceRationaleOverride
European Centre for Emerging Competencies and Technologies 70% ollama
The organization's focus on STEM, robotics, and digital transformation aligns wi…

The organization's focus on STEM, robotics, and digital transformation aligns with the opportunity's emphasis on bio-printing of living cells for regenerative medicine. The domain overlap is strong, particularly in Health (opportunity) and Adult Education / Vocational Education and Training (VET) (organization), but the absence of a clear match in 'Regenerative Medicine' prevents a perfect score.

Override
Novatex Solutions LTD 26% ollama
The opportunity's 'Health' and 'Research & Development' domains align with the o…

The opportunity's 'Health' and 'Research & Development' domains align with the organization's 'Digital Transformation', 'ICT Research & Innovation', and 'Health technologies' domains. Additionally, the opportunity's focus on digital solutions overlaps with the organization's expertise in AI, Big Data, and data analytics. [Weighted score: 40% AI judgment (65%) + 0% domain/technology tag overlap (35%) = 26%]

Override